Portal de investigación
ESTUDIO DE FASE 3, ALEATORIZADO, EN DOBLE CIEGO Y CONTROLADO CON PRINCIPIO ACTIVO, DE LA EFICACIA Y LA SEGURIDAD DE AFLIBERCEPT A DOSIS ALTAS EN PACIENTES CON DEGENERACIÓN MACULAR NEOVASCULAR RELACIONADA CON LA EDAD.
Datos básicos
- Protocolo:
- BAY86-5321/IMPACT20968/PULSAR
- EUDRACT:
- 2019-003851-12
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2021
- Año de finalización:
- 2023
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
Antireconverin antibodies in ocular chronic graft versus host disease: A new cause of nonparaneoplasic autoimmune retinopathy
Aguilar Gonzalez, Marina; (...); Espana Gregori, Enrique
Article. 10.1177/11206721221123779. 2022
Concomitant mutations in inherited retinal dystrophies: why the reproductive and therapeutic counselling should be addressed cautiously.
Rodriguez-Munoz, Ana; (...); Millan, Jose
Article. 10.1097/IAE.0000000000003103. 2021
COVID Obesity: A One-Year Narrative Review
Ovalle, Diana L. Palacios; (...); Soriano, Jose M.
Review. 10.3390/nu13062060. 2021
Challenges in Diabetic Macular Edema Management: An Expert Consensus Report
Udaondo P; (...); Ruiz-Moreno JM
Article. 10.2147/OPTH.S320948. 2021
Changes in nutritional status, body composition and associated symptomatology in hospitalized patients undergoing bone marrow transplantation: prospective longitudinal study
Cabanas-Alite, L; (...); Pinana, LL
Article. 10.14306/renhyd.25.2.1098. 2021
Economic burden of age-related macular degeneration in routine clinical practice: the RAMDEBURS study
Ruiz-Moreno, JM; (...); Udaondo, P
Article. 10.1007/s10792-021-01906-x. 2021
Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex ® Outcomes.
Udaondo, Patricia; (...); Garcia-Delpech, Salvador
Article. 10.2147/OPTH.S336865. 2021
Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema.
Udaondo Mirete P; (...); Espana-Gregori, Enrique
Article. 10.3390/jcm12010348. 2023
Neurotrophic Keratopathy Treated with Topical Recombinant Human Nerve Growth Factor (Cenegermin): Case Series Study with Long-Term Follow-Up.
Garcia-Delpech, Salvador; (...); Garcia-Teillard, Damian
Article. 10.1159/000525923. 2022
Rate and associations of inner retinal thinning in eyes with retinal vein occlusion and regressed macular oedema.
Cicinelli, Maria Vittoria; (...); Bandello, Francesco
Article. 10.1038/s41433-023-02647-0. 2023
Resolution of Angiographic Macular Leakage with Faricimab Versus Aflibercept in Patients with Diabetic Macular Edema in YOSEMITE/RHINE.
Goldberg, Roger A; (...); Sivaprasad, Sobha
Article. 10.1016/j.oret.2024.11.015. 2024
Systemic lupus erythematosus purtscher like retinopathy: Optical coherence tomography angiography assessment implications.
Garcia-Soler E; (...); Salom-Alonso D
Article. 10.1177/11206721231171705. 2023
Update on Current and Future Management for Diabetic Maculopathy.
Udaondo, Patricia; (...); Chakravarthy, Usha
Article. 10.1007/s40123-022-00460-8. 2022
Use of intravitreal rituximab and methotrexate in vitreoretinal lymphoma.
Rahhal-Ortuno, Miriam; (...); Diaz-Llopis, Manuel
Article. 10.1177/1120672120960589. 2020
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO-Is there any difference? the VITDEX study.
Iglicki, Matias; (...); Zur, Dinah
Article. 10.1038/s41433-022-01931-9. 2022